K-Pharma creates pharmaceuticals by utilizing early-stage neuro regenerative medicine and iPS drug discovery.
K Pharma has raised $12.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.
K Pharma's investors include Keio Innovation Initiative, ITOCHU Technology Ventures, DCI Partners, ICMG Partners, Kagoshima Development.
K Pharma is headquartered in Fujisawa, Japan.
K-Pharma creates pharmaceuticals by utilizing early-stage neuro regenerative medicine and iPS drug discovery.
K Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"K Pharma — Funding & Investors." VCBacked, May 24, 2022, https://www.vcbacked.co/company/k-pharma. Accessed August 14, 2026.
VCBacked. (2022). K Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/k-pharma
{{cite web |title=K Pharma — Funding & Investors |url=https://www.vcbacked.co/company/k-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated